People who suffer from arthritis can’t wait for a cure. Our team offers improved access to help find relief as soon as possible via the many new therapies now available. We provide care to adult rheumatology patients at our south Tucson outpatient clinic along with a full infusion service delivering state-of-the-art biologic therapies and intravenous osteoporosis medication, also available for outside referrals. Bone density measurements are available onsite as is a full service phlebotomist...

C. Kent Kwoh, MD
Chief, Division of Rheumatology

Rheumatology

Dedicated to eradicating arthritis as a cause of human suffering through biomedical research, teaching and patient care, the Division of Rheumatology and its affiliated UA Arthritis Center were among the first to employ a multidisciplinary approach to combat arthritis and bone and connective tissue disease.

The Center’s research areas include innovative surgical techniques, use of new drug and other therapies, reduction of costs related to arthritis care, development of artificial joints and major new treatments in rheumatoid arthritis, lupus, osteoarthritis, scleroderma, vasculitis and other related diseases.

The University of Arizona Division of Rheumatology began as the Clinical Immunology Section of the UA Department of Medicine in 1968 and was led by John “Jack” Boyer, MD, until 1983, at which point it was the Section of Rheumatology/Allergy & Immunology. It now operates largely through the UA Arthritis Center, which was founded in 1985 by then section chief Eric P. Gall, MD, and Robert G. Volz, MD. A renowned expert in joint diseases, C. Kent Kwoh, MD, became chief of the Division of Rheumatology and Center director in 2013, coming from the University of Pittsburgh Arthritis Institute where he had been director of clinical research and headed three related National Institutes of Health-funded projects.

Integrating research and patient care continues as a major emphasis for the Division of Rheumatology. Much of the work is collaborative with a multidisciplinary focus that also draws upon the strengths of other divisions, departments and colleges within the UA Health Sciences, including geriatric and orthopedic medicine and surgery.

News

UA-Led Study on Hyperglucagonemia, Type 2 Diabetes Picked Up by Journal of Endocrinology

The Journal of Endocrinology has published a paper with the UA’s Dr. Jennifer Stern as lead author on research that suggests the metabolic glucoregulatory disturbance in obesity that can result in type 2 diabetes may be driven by inappropriate fasting-induced regulation of glucagon, resulting in a static glucagon:insulin ratio…


ADA Awards $600K to Dr. Coletta to Study Mitochondrial Epigenetic Changes in Type 2 Diabetes Patients

Endocrinology’s Dr. Dawn Coletta received a three-year, $600,000 award from the American Diabetes Association (ADA) for a study titled “Unraveling the role of mitochondrial DNA methylation in type 2 diabetes.” With co-investigators Drs. Wayne Willis, Lawrence Mandarino and Janet Funk, this study will determine whether DNA methylation of the mitochondrial DNA impairs mitochondrial function in obese or type 2 diabetes insulin-resistant patients and could lead to therapies to address it…


Dr. Daruka Mahadevan Named Hem-Onc Chief at UT Health San Antonio, Mays Cancer Center

Dr. Daruka Mahadevan, a University of Arizona professor in the Division of Hematology and Oncology, co-leader of the Therapeutic Development Program and director of the Clinical Trials Phase I Program at the UA Cancer Center, was named chief of the Division of Hematology and Medical Oncology at the University of Texas, San Antonio, Department of Medicine and will lead that service line at the Mays Cancer Center at UT Health San Antonio. He’ll start in his new position Dec. 1…


Events

Sep
16
Benzodiazepine Withdrawal Symposium
Conference or Symposium

Sep
16
Benzodiazepine Withdrawal Symposium
Conference or Symposium

Sep
16
Benzodiazepine Withdrawal Symposium
Conference or Symposium